Urgent Call to Action for Affected Investors
Investors who have faced financial losses from Applied Therapeutics, Inc. (NASDAQ: APLT) are strongly urged to take immediate action regarding a significant legal case. The Law Offices of Howard G. Smith has announced a deadline for filing a lead plaintiff motion, providing an essential opportunity to participate in a class action lawsuit that seeks to address these concerns. The timeline for filing motions extends until February 18, 2025, making it crucial for affected individuals to understand their rights during this period.
Understanding the Situation
What Led to the Decline?
Recent disclosures from Applied Therapeutics have alarmed investors. On November 27, 2024, the company reported receiving a Complete Response Letter from the U.S. Food and Drug Administration (FDA). This letter indicated that the FDA was unable to approve the New Drug Application (NDA) for govorestat, the company’s primary treatment for Classic Galactosemia, citing numerous deficiencies in their clinical application.
The impact on the stock price was devastating, as shares dropped sharply by $6.54 or 76.3%, closing at $2.03 per share by November 29, 2024. Investors were understandably shaken by this announcement.
Further Complications
Adding to the turmoil, on December 2, 2024, the company noted receiving a warning letter from the FDA. This letter addressed concerning issues about electronic data capture, which the company believed had been resolved through prior communications. Yet, this news caused further losses, with the stock price falling by $0.46, representing a 26.3% drop, leaving shares at $1.29 as of December 5, 2024.
Details of the Allegation
The complaint articulates that during the outlined class period, the company and its executives made misleading statements that concealed negative information about the business's health and prospects. It is claimed that they failed to disclose critical information about their non-adherence to trial protocols and good clinical practices. This not only misled investors but left them with unfounded optimism regarding the company's financial status and potential for recovery.
What Steps Should Affected Investors Take?
If you’ve invested in Applied Therapeutics during the noted class period and are concerned about the implications of these recent developments, it’s essential to reach out to legal counsel who can assist in navigating this situation. You have until February 18, 2025, to ask the court to appoint you as a lead plaintiff if you meet the necessary legal requirements.
Contact Information
If you're interested in learning more about this class action or have questions about your legal rights, please connect with the Law Offices of Howard G. Smith. They are available to help investors understand their options and actively participate in the ongoing lawsuit. The firm is located at:
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Frequently Asked Questions
What is the deadline for filing a lead plaintiff motion?
The deadline to file a lead plaintiff motion for the lawsuit is February 18, 2025.
What are the main allegations against Applied Therapeutics?
The allegations include that the company made misleading statements about its compliance with trial protocols and that it concealed material adverse facts affecting its business and operations.
What should I do if I invested in APLT during the class period?
If you invested during the class period, it is advisable to consult a legal expert to discuss your potential role in the class action and your rights as an investor.
How can I contact the Law Offices of Howard G. Smith?
You can reach them by phone at (215) 638-4847 or email for more information on participating in the lawsuit.
Is there any cost for joining the class action?
There is typically no cost to join a class action lawsuit at this stage; legal fees are often handled on a contingency basis.
